Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Luis M. de la Maza, Toni L Darville & Sukumar Pal. (2021) Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?. Expert Review of Vaccines 20:4, pages 421-435.
Read now
Read now
Articles from other publishers (20)
Soheil Sadr, Parian Poorjafari Jafroodi, Mohammad Javad Haratizadeh, Zahra Ghasemi, Hassan Borji & Ashkan Hajjafari. (2023) Current status of nano‐vaccinology in veterinary medicine science. Veterinary Medicine and Science.
Crossref
Crossref
Mir Javid Iqbal, Tooba Hamdani, Husain Z. Attarwala & Mansoor M. Amiji. 2023. Nanomedicines for the Prevention and Treatment of Infectious Diseases. Nanomedicines for the Prevention and Treatment of Infectious Diseases
367
402
.
Lianfei Fang, Jin Liu, Zeyang Liu & Huifang Zhou. (2022) Immune modulating nanoparticles for the treatment of ocular diseases. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Yadollah Omidi, Mohammad M. Pourseif, Hossein Omidian & Jaleh Barar. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials
437
468
.
Yuye Wu, Dheerendranath Battalapalli, Mohammed J. Hakeem, Venkatarao Selamneni, Pengfei Zhang, Mohamed S. Draz & Zhi Ruan. (2021) Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Abisola Abisoye-Ogunniyan, Isabella M. Carrano, Dina R. Weilhammer, Sean F. Gilmore, Nicholas O. Fischer, Sukumar Pal, Luis M. de la Maza, Matthew A. Coleman & Amy Rasley. (2021) A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections. Frontiers in Pharmacology 12.
Crossref
Crossref
Željka Vanić, May Wenche Jøraholmen & Nataša Škalko-Basnet. (2021) Nanomedicines for the topical treatment of vulvovaginal infections: Addressing the challenges of antimicrobial resistance. Advanced Drug Delivery Reviews 178, pages 113855.
Crossref
Crossref
Shruthi Polla Ravi, Yasmeen Shamiya, Aishik Chakraborty, Cynthia Elias & Arghya Paul. (2021) Biomaterials, biological molecules, and polymers in developing vaccines. Trends in Pharmacological Sciences 42:10, pages 813-828.
Crossref
Crossref
Carmen Teresa Celis-Giraldo, Julio López-Abán, Antonio Muro, Manuel Alfonso Patarroyo & Raúl Manzano-Román. (2021) Nanovaccines against Animal Pathogens: The Latest Findings. Vaccines 9:9, pages 988.
Crossref
Crossref
Rajnish Sahu, Saurabh Dixit, Richa Verma, Skyla A. Duncan, Lula Smith, Guillermo H. Giambartolomei, Shree R. Singh & Vida A. Dennis. (2021) Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge. Frontiers in Immunology 12.
Crossref
Crossref
Rajnish Sahu, Saurabh Dixit, Richa Verma, Skyla A. Duncan, Mamie T. Coats, Guillermo H. Giambartolomei, Shree R. Singh & Vida A. Dennis. (2020) A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice. Nanomedicine: Nanotechnology, Biology and Medicine 29, pages 102257.
Crossref
Crossref
Liroy Lugasi, Igor Grinberg, Rivka Sabag, Ravit Madar, Haim Einat & Shlomo Margel. (2020) Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone. Molecules 25:17, pages 4013.
Crossref
Crossref
Morenikeji Deborah Akinlotan, Dann G. Mallet & Robyn P. Araujo. (2020) Mathematical modelling of the role of mucosal vaccine on the within-host dynamics of Chlamydia trachomatis. Journal of Theoretical Biology 497, pages 110291.
Crossref
Crossref
J. El-Jakee, Mahmoud D. El-Hariri, Mona A. El-Shabrawy, Afaf A. Khedr, Riham H. Hedia, Eman A. Khairy, E. S. Gaber & Eman Ragab. (2020) Efficacy of a prepared tissue culture-adapted vaccine against Chlamydia psittaci experimentally in mice. Veterinary World 13:11, pages 2546-2554.
Crossref
Crossref
Edwin David G. McIntosh. (2020) Development of vaccines against the sexually transmitted infections gonorrhoea, syphilis, Chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus. Therapeutic Advances in Vaccines and Immunotherapy 8, pages 251513552092388.
Crossref
Crossref
Richa Verma, Rajnish Sahu, Desh Deepak Singh & Timothy E. Egbo. (2019) A CRISPR/Cas9 based polymeric nanoparticles to treat/inhibit microbial infections. Seminars in Cell & Developmental Biology 96, pages 44-52.
Crossref
Crossref
Changshun Hou, Bo Yi, Jieke Jiang, Yung-Fu Chang & Xi Yao. (2019) Up-to-date vaccine delivery systems: robust immunity elicited by multifarious nanomaterials upon administration through diverse routes. Biomaterials Science 7:3, pages 822-835.
Crossref
Crossref
E. David G. McIntosh. (2019) Development of vaccines against gonorrhoea, syphilis, chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus. Clinical Microbiology and Antimicrobial Chemotherapy 21:4, pages 253-260.
Crossref
Crossref
Donald E. Greydanus, Joav Merrick & Maria Demma Cabral. (2018) Pelvic inflammatory disease: management requires a patient, prudent, prejudice-free provider. International Journal of Adolescent Medicine and Health 0:0.
Crossref
Crossref
Richa Verma, Rajnish Sahu, Saurabh Dixit, Skyla A. Duncan, Guillermo H. Giambartolomei, Shree R. Singh & Vida A. Dennis. (2018) The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses. Frontiers in Immunology 9.
Crossref
Crossref